Sandra Levy
ARTICLES BY THIS AUTHOR
- 12/16/2019
Benzer Pharmacy selects AshHEALTH for group purchasing, pharmacy acquisition services
AshHEALTH will be responsible for Benzer Pharmacy's national group purchasing organization and pharmacy acquisition strategy. - 12/16/2019
Amgen prevails in Epogen patent dispute with Hospira
An appeals court has affirmed a lower court verdict that upholds $70 million in damages awarded in September 2017. - 12/16/2019
Prasco launches authorized generic NuvaRing
In partnership with Merck, Prasco is launching an authorized generic of NuvaRing. - 12/15/2019
CVS Health completes rollout of time-delay safes in Virginia
All 353 CVS Pharmacy locations in Virginia are now using time-delay safe technology. - 12/15/2019
CVS Health to provide $750K to California Harm Reduction Coalition
CVS Health’s three-year partnership with the Harm Reduction Coalition will help address prescription opioid abuse across California. - 12/15/2019
Amneal to acquire majority interest in AvKARE
With its acquisition of AvKARE, Amneal enters the federal healthcare market. - 12/12/2019
Publix builds out differentiated specialty-at-retail offering
Publix — DSN's 2019 Pharmacy Innovator of the Year — has built a specialty operation that executives said has improved its ability to care for patients on specialty therapies, as well as access to limited-distribution drugs. - 12/11/2019
Elite, SunGen get FDA nod for generic Adderall XR
Adderall XR and its generics had a market value of $1.3 billion for the 12 months ended October 2019, according to IQVIA. - 12/11/2019
NACDS Foundation Dinner raises nearly $1.9M for public health, patient care initiatives
The NACDS Foundation Dinner raised funds for health initiatives, and also honored two heroes for work in preventing and treating opioid abuse. - 12/11/2019
Amneal gets FDA green light for first generic NuvaRing
NuvaRing had a market value of roughly $976 million for the 12 months ended Oct. 31, 2019, according to IQVIA.
